2024
DOI: 10.3390/molecules29092050
|View full text |Cite
|
Sign up to set email alerts
|

Application of Deferoxamine in Tissue Regeneration Attributed to Promoted Angiogenesis

Haijun Shen,
Yane Ma,
Yi Qiao
et al.

Abstract: Deferoxamine, an iron chelator used to treat diseases caused by excess iron, has had a Food and Drug Administration-approved status for many years. A large number of studies have confirmed that deferoxamine can reduce inflammatory response and promote angiogenesis. Blood vessels play a crucial role in sustaining vital life by facilitating the delivery of immune cells, oxygen, and nutrients, as well as eliminating waste products generated during cellular metabolism. Dysfunction in blood vessels may contribute s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 181 publications
0
0
0
Order By: Relevance